$ALLR
Allarity Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
ALLR chart
What traders are saying about $ALLR
Latest postsAllarity Therapeutics, Inc. news
- Allarity Therapeutics files for $100 million SPAC offering By Investing.com
Investing.com UK ·
- Allarity Therapeutics, Inc. (ALLR) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Allarity Announces First Revenue-Generating Laboratory Services Contract
TipRanks ·
- ALLR Q3'26 Earnings: revenue estimate is 0 USD
TradingView ·
- Allarity Therapeutics, Inc. (ALLR) Seasonal returns chart
Yahoo Finance UK ·
- CHOSA enters into an agreement with a CLIA-certified laboratory partner for Platin-DRP® in the USA - first revenue expected summer 2027
Yahoo Finance ·
- Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
Yahoo Finance ·
- Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock Now
Yahoo Finance ·
- New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
Yahoo Finance ·
- Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
Yahoo Finance ·
- Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Yahoo Finance ·
- Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
Yahoo Finance ·
Allarity Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$11.2M | -$24.5M | -$11.9M | -$16.1M |
| Diluted EPS | – | – | $-10.26 | $-3093.42 |
| Total assets (year end) | $18.3M | $22.6M | $11.9M | $14.5M |
| Cash and equivalents (year end) | $14.7M | $19.5M | $166,000 | $2.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Allarity Therapeutics, Inc.
- Ticker
- ALLR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1860657
Frequently asked questions
What exchange is Allarity Therapeutics, Inc. listed on?
Allarity Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ALLR.
What industry is Allarity Therapeutics, Inc. in?
Allarity Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Allarity Therapeutics, Inc. headquartered?
Allarity Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Allarity Therapeutics, Inc.'s fiscal year end?
Allarity Therapeutics, Inc.'s fiscal year ends on December 31.